Yarrow Bioscience Inc (YARW)

Yarrow Bioscience Inc (YARW) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $183M; returns 1 day -1.7%, 1 week +5.2%.

Yarrow Bioscience, Inc. (formerly VYNE Therapeutics Inc.) is a clinical-stage biopharmaceutical company specialized in developing targeted biotherapeutics for autoimmune thyroid diseases.

Groups YARW belongs to

• Recent Reverse Splits
• Clinical Stage Biopharma
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Autoimmune Diseases
• Antibody Therapeutics
• Monoclonal Antibodies
• Unmet Medical Needs
• R&D
• Healthcare

YARW financial model: income statement, cash flow and balance sheet